Astrazeneca (AZN) Return on Equity [ROE] (2009 - 2026)
Astrazeneca's Return on Equity [ROE] came in at 21.39% for Q2 2026, up 2.07 percentage points from 19.32% a year earlier but down 0.24 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Astrazeneca's Return on Equity [ROE] was 22.84%, up 5.25 percentage points from FY2024.
- Return on Equity [ROE] has increased in each of the last four years, with a five-year change of +2.05 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 17.59% in FY2024 (+1.95 pp), 15.64% in FY2023 (+7.01 pp), 8.63% in FY2022 (+8.21 pp) and 0.42% in FY2021 (-20.38 pp).
- The five-year range for quarterly Return on Equity [ROE] is -3.45% (Q2 2022) to 21.63% (Q1 2026).
- Year-over-year, Return on Equity [ROE] has increased for eight consecutive quarters, with an average year-over-year change of +2.58 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2023 (a gain of 20.30 percentage points), and the weakest in Q1 2022 (a drop of 29.10 percentage points).
- Business Quant data shows AZN's Return on Equity [ROE] at 21.63% (Q1 2026), 21.61% (Q4 2025) and 20.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 43.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.39% |
| Mar 31, 2026 | 21.63% |
| Dec 31, 2025 | 21.61% |
| Sep 30, 2025 | 20.72% |
| Jun 30, 2025 | 19.32% |
| Mar 31, 2025 | 18.98% |
| Dec 31, 2024 | 17.24% |
| Sep 30, 2024 | 16.17% |
| Jun 30, 2024 | 16.72% |
| Mar 31, 2024 | 16.53% |
| Dec 31, 2023 | 15.61% |
| Sep 30, 2023 | 15.82% |
| Jun 30, 2023 | 16.85% |
| Mar 31, 2023 | 12.92% |
| Dec 31, 2022 | 9.12% |
| Sep 30, 2022 | 5.75% |
| Jun 30, 2022 | -3.45% |
| Mar 31, 2022 | -2.80% |
| Dec 31, 2021 | 0.29% |
| Sep 30, 2021 | 5.27% |
API Access
Astrazeneca Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();